Type I Interferons in Systemic Lupus Erythematosus: A Journey from Bench to Bedside

Dysregulation of type I interferons (IFNs) has been implicated in the pathogenesis of systemic lupus erythematosus (SLE) since the late 1970s. The majority of SLE patients demonstrate evidence of type I IFN pathway activation; however, studies attempting to address the relationship between type I IF...

Descripción completa

Detalles Bibliográficos
Autores principales: Sim, Tao Ming, Ong, Siying Jane, Mak, Anselm, Tay, Sen Hee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910773/
https://www.ncbi.nlm.nih.gov/pubmed/35269647
http://dx.doi.org/10.3390/ijms23052505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910773/
https://www.ncbi.nlm.nih.gov/pubmed/35269647
http://dx.doi.org/10.3390/ijms23052505

Ejemplares similares